Extended-Duration Thromboprophylaxis With Enoxaparin After Arthroscopic Surgery of the Anterior Cruciate Ligament: A Prospective, Randomized, Placebo-Controlled Study

      Purpose: To compare the efficacy of extended-duration thromboprophylaxis with enoxaparin for 20 days in the outpatient setting with in-hospital thromboprophylaxis with enoxaparin (3 to 8 days) only in patients who had undergone arthroscopic surgery of the anterior cruciate ligament (ACL). Methods: This was a single-center, randomized, double-blind, prospective trial investigating 175 ACL surgery patients. All patients received subcutaneous enoxaparin 40 mg once daily 12 to 18 hours presurgery and 3 to 8 days postsurgery during hospitalization. After discharge, patients were randomized to 40 mg enoxaparin (n = 87) or placebo (n = 88) self-administered once daily subcutaneously for 20 days. The primary efficacy end-points were the incidences of symptomatic and asymptomatic deep vein thrombosis (DVT) and pulmonary embolism (PE). Primary safety endpoints were the incidences of major and minor bleeding. Results: Thirty-five patients were excluded because of noncompliance with the predefined protocol. No patient had DVT confirmed by magnetic resonance venography (MRV) at discharge. Of 140 patients in the intention-to-treat population, 2 (2.8%) who received postdischarge enoxaparin (n = 72) and 28 (41.2%) who received placebo (n = 68) had DVT confirmed by MRV (P < .001). No patients were diagnosed with PE. No major bleeds occurred. Minor bleeding occurred in 13 (2.5%) out of 513 postdischarge enoxaparin injections and 10 (2.0%) out of 492 placebo injections (P = .595). Risk factors for DVT during the 20 days postdischarge were age >30 years (odds ratio [OR]: 3.241; 95% confidence interval [CI], 1.015 to 10.349) and immobilization before surgery (OR 18.195; 95% CI, 2.046 to 161.837). Conclusions: Extended-duration postdischarge thromboprophylaxis for 20 days with enoxaparin in the outpatient setting significantly reduced the incidence of DVT in ACL surgery patients compared with enoxaparin limited to in-hospital thromboprophylaxis without increasing major or minor bleeding. Level of Evidence: Level I, high-quality randomized controlled trial.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Arthroscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Small N.C.
        Complications in arthroscopic surgery performed by experienced arthroscopists.
        Arthroscopy. 1988; 4: 215-221
        • Demers C.
        • Marcoux S.
        • Ginsberg J.S.
        • Laroche F.
        • Cloutier R.
        • Poulin J.
        Incidence of venographically proved deep vein thrombosis after knee arthroscopy.
        Arch Intern Med. 1998; 158: 47-50
        • Michot M.
        • Conen D.
        • Holtz D.
        • et al.
        Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: A randomized trial of prophylaxis with low-molecular-weight heparin.
        Arthroscopy. 2002; 18: 257-263
        • Williams Jr, J.S.
        • Hulstyn M.J.
        • Fadale P.D.
        • et al.
        Incidence of deep vein thrombosis after arthroscopic knee surgery: A prospective study.
        Arthroscopy. 1995; 11: 701-705
        • Dahl O.E.
        • Gudmundsen T.E.
        • Haukeland L.
        Late occurring clinical deep vein thrombosis in joint-operated patients.
        Acta Orthop Scand. 2000; 71: 47-50
        • Cullison T.R.
        • Muldoon M.P.
        • Gorman J.D.
        • Goff W.B.
        The incidence of deep venous thrombosis in anterior cruciate ligament reconstruction.
        Arthroscopy. 1996; 12: 657-659
        • Schippinger G.
        • Wirnsberger G.H.
        • Obernosterer A.
        • Babinski K.
        Thromboembolic complications after arthroscopic knee surgery.
        Acta Orthop Scand. 1998; 69: 144-146
        • Wirth T.
        • Schneider B.
        • Misselwitz F.
        • et al.
        Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (reviparin): Results of a randomized controlled trial.
        Arthroscopy. 2001; 17: 393-399
        • Delis K.T.
        • Hunt N.
        • Strachan R.K.
        • Nicolaides A.N.
        Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
        Thromb Haemost. 2001; 86: 817-821
        • Eynon A.M.
        • James S.
        • Leach P.
        Thromboembolic events after arthroscopic knee surgery.
        Arthroscopy. 2004; 20: S23-S24
        • Kieser C.
        A review of the complications of arthroscopic knee surgery.
        Arthroscopy. 1992; 8: 79-83
        • Geerts W.H.
        • Pineo G.F.
        • Heit J.A.
        • et al.
        Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
        Chest. 2004; 126: 338S-400S
        • Pauschert R.
        • Diehm C.
        • Stammler F.
        [Guidelines for the prevention of thrombosis in orthopedics].
        Z Orthop Ihre Grenzgeb. 1998; 136: 471-479
        • Durica S.
        • Raskob G.
        • Johnson C.
        • et al.
        Incidence of deep-vein thrombosis after arthroscopic knee surgery.
        Thromb Haemost. 1997; 79: S183
        • Bergqvist D.
        • Lowe G.
        Venous thromboembolism in patients undergoing laparoscopic and arthroscopic surgery and in leg casts.
        Arch Intern Med. 2002; 162: 2173-2176
        • Irani S.
        • Conen D.
        [Should postoperative thromboembolism preventions be extended to the post-hospitalization phase].
        Schweiz Med Wochenschr. 1996; 126: 386-391
        • Dahl O.E.
        • Andreassen G.
        • Müeller C.
        • et al.
        The effect of prolonged thromboprophylaxis with dalteparin on the frequency of deep venous thrombosis (DVT) and pulmonary embolism (PE) 35 days after hip replacement surgery (HRS).
        Thromb Haemost. 1995; 73 (abstr): 1094
        • Planes A.
        • Vochelle N.
        • Darmon J.Y.
        • Fagola M.
        • Bellaud M.
        • Huet Y.
        Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: Double-blind randomised comparison of enoxaparin versus placebo.
        Lancet. 1996; 348: 224-228
        • Imperiale T.F.
        • Speroff T.
        A meta-analysis of methods to prevent venous thromboembolism following total hip replacement.
        JAMA. 1994; 271: 1780-1785
        • Clancy W.G.
        Intra-articular reconstruction of the anterior cruciate ligament.
        Orthop Clin N Am. 1985; 16: 181-189
        • Carpenter J.P.
        • Holland G.A.
        • Baum R.A.
        • Owen R.S.
        • Carpenter J.T.
        • Cope C.
        Magnetic resonance venography for the detection of deep venous thrombosis: Comparison with contrast venography and duplex Doppler ultrasonography.
        J Vasc Surg. 1993; 18: 734-741
        • Baarslag H.J.
        • Van Beek E.J.
        • Reekers J.A.
        Magnetic resonance venography in consecutive patients with suspected deep vein thrombosis of the upper extremity: Initial experience.
        Acta Radiol. 2004; 45: 38-43
        • Stover M.D.
        • Morgan S.J.
        • Bosse M.J.
        • et al.
        Prospective comparison of contrast-enhanced computed tomography versus magnetic resonance venography in the detection of occult deep pelvic vein thrombosis in patients with pelvic and acetabular fractures.
        J Orthop Trauma. 2002; 16: 613-621
        • Hull R.D.
        • Hirsh J.
        • Carter C.J.
        • et al.
        Diagnostic efficacy of impedenace plethysmography for clinically suspected deep-vein thrombosis: A randomized trial.
        Ann Intern Med. 1985; 102: 21-28
        • Stringer M.D.
        • Steadman C.A.
        • Hedges A.R.
        • Thomas E.A.
        • Morley T.R.
        • Kakkar V.V.
        Deep vein thrombosis after elective knee surgery: An incidence study in 312 patients.
        J Bone Joint Surg Br. 1989; 71: 492-497
        • Caprini J.A.
        • Arcelus J.I.
        • Reyna J.J.
        Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease.
        Semin Hematol. 2001; 38: S12-S19